First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

N/ACompletedNCT00537901

King Faisal Specialist Hospital & Research Center100 enrolled

Overview

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Chemotherapy

Chemotherapy

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with metastatic cancer of colon or rectum

Effectiveness

Time frame: overall

Quality of life

Time frame: overall

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.